TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5657.46M
Enterprise Value 3549.57M
Trailing P/E N/A
Forward P/E 1-5.95
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)4,325.36
Price/Book (mrq)25.99
Enterprise Value/Revenue 33,615.60
Enterprise Value/EBITDA 6-3.15

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-114,736.84%

Management Effectiveness

Return on Assets (ttm)-120.44%
Return on Equity (ttm)-381.16%

Income Statement

Revenue (ttm)152k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)N/A
EBITDA -174.31M
Net Income Avi to Common (ttm)-173.48M
Diluted EPS (ttm)-2.30
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)68.81M
Total Cash Per Share (mrq)0.88
Total Debt (mrq)67k
Total Debt/Equity (mrq)0.28
Current Ratio (mrq)2.03
Book Value Per Share (mrq)0.31

Cash Flow Statement

Operating Cash Flow (ttm)-128.93M
Levered Free Cash Flow (ttm)-82.78M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.66
52-Week Change 3-42.81%
S&P500 52-Week Change 311.15%
52 Week High 316.00
52 Week Low 33.32
50-Day Moving Average 37.53
200-Day Moving Average 35.53

Share Statistics

Avg Vol (3 month) 32.39M
Avg Vol (10 day) 31.86M
Shares Outstanding 581.87M
Float 41.49M
% Held by Insiders 111.16%
% Held by Institutions 168.87%
Shares Short (Mar 29, 2019) 417.64M
Short Ratio (Mar 29, 2019) 44.98
Short % of Float (Mar 29, 2019) 426.74%
Short % of Shares Outstanding (Mar 29, 2019) 421.03%
Shares Short (prior month Feb 28, 2019) 413.19M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 256/1
Last Split Date 3Apr 30, 2012